採用
Mainz, Germany | full time | Job ID: 10540
About the role:
BioNTech’s late-stage and commercial products require expert stewardship to manage the technical lifecycle, ensuring compliance, innovation, and operational excellence. As the Director MS&T, you will be the technical voice of the product, advocating for regulatory compliance while bridging the gap between BioNTech’s business needs and technical execution. This strategic leadership role focuses on RNA and antibody commercial products, driving technical excellence from PPQ (Process Performance Qualification) through product launch, lifecycle management, and discontinuation.
Your contribution:
- Act as the technical voice of the product, ensuring compliance with regulatory dossiers and advocating for technical excellence.
- Develop and execute strategies for the technical lifecycle management of late-stage and commercial products, including RNA and antibody-based therapeutics.
- Lead the Commercial CMC Team, ensuring alignment with BioNTech’s business objectives and regulatory requirements.
- Drive late-stage technical transfer and Biologics License Application (BLA) readiness, ensuring seamless execution and compliance.
- Oversee Responses to Questions (RTQs), launch support, GMP manufacturing investigations, process monitoring, and Annual Product Reviews (APRs).
- Manage Post-Approval Change Management Plans (PACMP) to ensure product compliance and continuous improvement.
- Identify and mitigate product risks while driving technical improvements across the product lifecycle.
- Serve as a matrix product lead, providing guidance, training, and communication to MS&T staff.
- Build and maintain strategic alliances with key partners, including Pfizer, BMS, and other collaborators.
- Act as the primary interface for strategic partnerships, ensuring alignment and collaboration on technical and regulatory objectives.
- Support product manufacturing by ensuring robust control strategies and compliance with regulatory standards.
- Lead investigations into GMP manufacturing issues, driving resolution and continuous improvement.
- Monitor and analyze product performance, ensuring alignment with quality and regulatory expectations.
A good match:
- Advanced degree (Master’s or Ph.D.) in Biotechnology, Biochemistry, Chemical Engineering, or a related field.
- Extensive experience in late-stage product development, commercial manufacturing, and technical lifecycle management.
- Proven track record in CMC leadership, including technical transfer, regulatory submissions, and post-approval change management.
- Deep understanding of RNA and antibody-based products, control strategies, and regulatory compliance.
- Demonstrated ability to lead cross-functional teams and manage complex technical projects.
- Excellent verbal and written communication skills, with the ability to effectively engage with internal teams and external partners.
- Strong interpersonal skills and experience managing strategic partnerships with global collaborators (e.g., Pfizer, BMS).
- Analytical mindset with a proactive approach to identifying and mitigating risks.
- Experience with Biologics License Applications (BLA) and Responses to Questions (RTQs).
- Familiarity with Good Manufacturing Practices (GMP) and Annual Product Reviews (APRs).
- Expertise in managing Post-Approval Change Management Plans (PACMP).
Your Benefits:
It's our priority to support you:
- Your flexibility: flexible hours | vacation account
- Your growth: Digital Learning | Performance & talent development | leadership development | Apprenticeships | LinkedIn Learning
- Your value: Your voice at the table | Culture on an equal footing | Opportunities to shape & impact | Support for your full potential
- Your health and lifestyle: Company bike
- Your mobility: Job ticket | Deutschlandticket
- Your life phases: Employer-funded pension | Childcare
Apply now
- We look forward to your application!
Apply to our Mainz, Germany location by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 10540 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Maintenance Shop Lead Tech
Republic Services · Eagle River, Wisconsin, United States of America

Field Service Supervisor
Thermo Fisher · Remote, Georgia, USA

Production Supervisor
BAE Systems · Chesapeake, Virginia, United States

Maintenance Supervisor (Afternoon Shift - 3-11pm)
Ford · Cincinnati, OH, United States, US

Production Supervisor (1st shift)
ZF Friedrichshafen ·
BioNTechについて

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
従業員数
Mainz that develops immunotherapies
本社所在地
$21.7B
企業価値
レビュー
4.0
10件のレビュー
ワークライフバランス
2.5
報酬
3.8
企業文化
4.2
キャリア
3.5
経営陣
3.2
75%
友人に勧める
良い点
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
改善点
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
給与レンジ
70件のデータ
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0件のレポート
$53,767
年収総額
基本給
$21,507
ストック
$26,884
ボーナス
$5,377
$37,637
$69,897
面接体験
1件の面接
難易度
3.0
/ 5
期間
14-28週間
面接プロセス
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
よくある質問
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
ニュース&話題
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
4d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago